Show simple item record

dc.contributor.authorFrye, Victoria
dc.contributor.authorNandi, Vijay
dc.contributor.authorHirshfield, Sabina
dc.contributor.authorChiasson, Mary Ann
dc.contributor.authorWilton, Leo
dc.contributor.authorUsher, DaShawn
dc.contributor.authorHoover, Donald R
dc.contributor.authorKoblin, Beryl A
dc.date.accessioned2022-10-03T19:22:05Z
dc.date.available2022-10-03T19:22:05Z
dc.identifier.citationFrye V, Nandi V, Hirshfield S, Chiasson MA, Wilton L, Usher D, Hoover DR, Koblin BA. Brief Report: Randomized Controlled Trial of an Intervention to Match Young Black Men and Transwomen Who Have Sex With Men or Transwomen to HIV Testing Options in New York City (All About Me). J Acquir Immune Defic Syndr. 2020 Jan 1;83(1):31-36. doi: 10.1097/QAI.0000000000002223. PMID: 31809359; PMCID: PMC7882213.en_US
dc.identifier.eissn1944-7884
dc.identifier.doi10.1097/QAI.0000000000002223
dc.identifier.pmid31809359
dc.identifier.urihttp://hdl.handle.net/20.500.12648/7642
dc.description.abstractBackground: HIV testing is critical to HIV prevention and care. Infrequent HIV testing and late HIV diagnosis have been observed among young Black men who have sex with men and transwomen. Novel interventions to increase HIV testing rates among young Black men who have sex with men and transwomen are needed. Methods: A randomized controlled trial among 236 young Black men and transwomen who have sex with men or transwomen evaluated the efficacy of an intervention that included completion of a brief survey and receipt of a personalized recommendation of an optimal HIV testing approach. Participants completed a computerized baseline assessment and were randomized to electronically receive either a personalized recommendation or standard HIV testing information. Follow-up surveys were conducted online at 3 and 6 months. Results: Retention was 92% and 93% at 3-month and 6-month follow-up, respectively. At baseline, 41% of participants reported that they tested for HIV in the past 3 months and another 25% between 4 and 6 months ago. Intent-to-treat analyses found that participants randomized to the experimental arm (personalized recommendation) were not significantly more likely to test for HIV compared with participants in the standard HIV testing information control arm at 3 months (76% vs. 71%; P = 0.40) and 6 months (73% vs. 72%; P = 0.81), respectively. Conclusions: This study evaluated an innovative intervention to increase HIV testing by matching individuals to optimal HIV testing approaches. Participants in both arms increased past 3-month HIV testing, suggesting that providing information on options and/or raising risk awareness is sufficient to significantly increase HIV testing. Trial registration: ClinicalTrial.gov NCT02834572 https://clinicaltrials.gov/ct2/show/NCT02834572.en_US
dc.language.isoenen_US
dc.relation.urlhttps://journals.lww.com/jaids/Fulltext/2020/01010/Brief_Report__Randomized_Controlled_Trial_of_an.5.aspxen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleBrief Report: Randomized Controlled Trial of an Intervention to Match Young Black Men and Transwomen Who Have Sex With Men or Transwomen to HIV Testing Options in New York City (All About Me).en_US
dc.typeArticle/Reviewen_US
dc.source.journaltitleJournal of acquired immune deficiency syndromes (1999)en_US
dc.source.volume83
dc.source.issue1
dc.source.beginpage31
dc.source.endpage36
dc.source.countryUnited States
dc.source.countryUnited States
dc.source.countryUnited States
dc.source.countryUnited States
dc.description.versionVoRen_US
refterms.dateFOA2022-10-03T19:22:06Z
dc.description.institutionSUNY Downstateen_US
dc.description.departmentSTAR Programen_US
dc.description.degreelevelN/Aen_US
dc.identifier.journalJournal of acquired immune deficiency syndromes (1999)


Files in this item

Thumbnail
Name:
Brief_Report__Randomized_Contr ...
Size:
92.97Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International